Pandemic losses remembered in Milton Keynes
'Tangible Actions"
"It's important that we learn from the experiences of the bereaved and that the terrible mistakes made during the pandemic are never repeated again," said Ms Mirza in an address at the event."The Covid inquiry has gone some way to documenting the pain of loss, it is, however, important that the learning and the evidence presented are translated into tangible actions."
The Covid-19 Day of Reflection was organised by Covid-19 Families UK.Charity founder, Deborah Lewis, whose father died during the pandemic, told the BBC that people were "still struggling" with grief.She added: "It is not only important to remember the losses, which is primarily what we do, but to remember that even though the pandemic has moved on, people are still struggling with grief."The Covid public inquiry is ongoing and earlier this month started four weeks of hearings, looking into the purchase and distribution of billions of pounds' worth of medical equipment during the pandemic.Bereaved people also reflected on the pandemic at events in Stevenage, Harlow, Peterborough and King's Lynn.
Follow Beds, Herts and Bucks news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
14 hours ago
- Scottish Sun
Shop-bought health tests not fit for purpose, warn experts – as they present ‘significant risk' for wrong diagnosis
The self-test market is booming in Britain TESTING TIMES Shop-bought health tests not fit for purpose, warn experts – as they present 'significant risk' for wrong diagnosis Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) SHOP-BOUGHT medical tests are unreliable and need tougher regulation, say scientists. The kits are readily available from supermarkets for checking health factors like high cholesterol, vitamin deficiencies, fertility and prostate problems. Sign up for Scottish Sun newsletter Sign up 1 Self-testing became normal during the Covid pandemic Credit: Getty But experts warn 'evidence for their benefit is lacking'. A study by the University of Birmingham found many cannot back up claims about their accuracy. Testing found many have confusing or unreadable instructions, and customers often do not know what to do with their results. Scientists said they should go through more stringent quality checks and be regulated like medical products. Professor Jon Deeks said: 'Current regulations are not adequately protecting consumers. 'For matters of our health, it is important that the evidence upon which health decisions are made is available and can be scrutinised.' Kits cost as little as £1.89 There is a booming market for the tests, which mostly work like Covid lateral flow tests, and the UK industry is set to be worth half a billion pounds by 2030. Researchers bought 30 of the kits from shops around Birmingham, costing between £1.89 and £39.99, and evaluated them. They found at least 18 had 'high risk' problems that might lead to a wrong result or decision. Eleven had equipment quality issues, 10 did not have a proper sampling process and 15 had issues with the instructions or advice on what to do with the results. British Heart Foundation video explains what exactly is meant by the risk of high cholesterol Those with problems included tests for menopause hormones, kidney function, vitamin D and thyroid function. In one example, Prof Deeks said the self-tests for prostate-specific antigen (PSA) levels, a marker of prostate health, were fixed at a certain concentration level. However, 'if you're age 70 you need to have your PSA done at a very different level to when you're 20', he said. False results could put strain on the NHS Dr Clare Davenport said: 'A good test should be clear about who and when to use it. 'It should be easy to use and easy to interpret. 'We expect it to be accurate and we expect it to be evidence-based if it's going to be sold to the general public, with clear advice of what to do with next steps. 'Unfortunately, what we found is that actually many tests gave unclear or missing guidance. 'On one side, if you get a false positive result that might lead to unnecessary extra testing, unnecessary treatments or just anxiety to patients. 'And on the other side, you may have a false negative and you get this false reassurance, which can lead to missed or delayed diagnosis and delayed treatment with obviously worse outcomes for patients. 'All of this can have an impact on health care demand. 'The wrong test or result can then lead to unnecessary or additional appointments, investigations and treatments and a higher burden on the NHS.' Dr Bernie Croal, president of the Royal College of Pathologists, said: 'There are significant risks to patients when poor quality tests are carried out inappropriately.' However, the team said that in the future, home tests could have great potential for patient care. The Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medical products, said it would look at the findings. It issued its own warning about the kits in June and said they must not be taken as real medical advice. The MHRA said: 'Self-tests can provide helpful insights, but they're not a substitute for medical advice or a diagnosis. 'If you're unsure about a result, or have symptoms you're worried about, speak to a GP, pharmacist or other healthcare professional before making any decisions.' The research was published in the British Medical Journal.
BBC News
19 hours ago
- BBC News
Covid Inquiry: 'Lessons can be learned' from care home lockdowns
Locking down care homes to protect residents from Covid was "one of the most difficult decisions" that had to be made throughout the pandemic, Northern Ireland's former commissioner for older people has told the UK Covid Lynch said his office heard distressing stories from families about loved ones whose conditions deteriorated due to not receiving family said he hoped lessons can be learned and that concrete changes can be made to how care homes will cope in the case of a future inquiry, sitting in London, is examining the impact of the pandemic on social care including people who lived in care homes and those receiving domiciliary care at home. Visitor ban consequences 'more serious than we initially expected' "I was aware of the impact that this was going to have on people, but at that stage it seemed like people's right to protect their lives trumped everything else," Mr Lynch told the inquiry that he had supported the visiting policy following advice from experts that fewer people going in and out of care homes from the community would reduce the risk for people in those care home he said that after a period of time he realised that the negative side of that policy was "very serious and probably more serious than we initially expected"."It was clear to me that for many older people that that system meant that they didn't see family members face to face for the last weeks or months of their lives."It was a very awful position to be in and I think in the future we need to weigh up the risk associated with contracting the virus and putting in place measures that allows continued social contact and direct human contact with family members," he added. Mr Lynch said that in those early stages of the pandemic care homes were in the firing line and it felt greater attention was being given to hospitals instead of care homes, when the care homes were clearly "more vulnerable". In March 2020, 23% of the population in Northern Ireland were older people, which is defined as those aged 60 years and former commissioner said from the outset of the pandemic he reminded officials that everyone needed to stop referring to care homes as buildings but instead as people's inquiry is examining how Northern Ireland dealt with personal protective equipment (PPE), testing and tracing the infection, discharge policy and Lynch said that in many of these areas "Northern Ireland played catch up" and testing could have been introduced at an earlier stage, but instead there was a feeling of "push back."He said, within the first couple of months, they knew the "devastating impact" the pandemic was having on care told the inquiry that experts were telling him that testing and tracing the virus was "critical" for care homes to get a handle on it, but that he felt testing was "far too slow in coming". Testing 'could have been done weeks earlier' When a testing programme was introduced by the Department of Health which became regular, Mr Lynch said he had " deep frustration" at the speed of that and what he saw was "a lack of urgency about how important that was in response to the pandemic".Mr Lynch claimed testing could have been introduced and ramped up earlier and that while resources may have been one of the issues, he did not believe it was entirely about said in the early stages there did not seem to be "a huge appetite" for testing, particularly in care home settings and that the roll out of testing could have been done weeks Lynch told the inquiry that the weaknesses of the social care sector for older people were "horribly exposed at the outset of the pandemic".He said that the pandemic had a devastating impact on older people and those with underlying health care problems who were at most risk."The nature of the virus was difficult to control once it got into those settings, " Mr Lynch asked about draft guidance that was issued by the DOH on 16 March 2020, Mr Lynch said the guidance was limited and there was little opportunity for others to influence it.
NBC News
19 hours ago
- NBC News
Summer Covid cases are rising across the U.S. — Is it time for a vaccine?
As Covid cases begin to rise this summer, many may be wondering: What are my risks, and is it time to get another vaccine? As of July 15, Covid cases were growing or likely growing in 27 states including Texas, Illinois, Kentucky, Virginia and Ohio, according to the Centers for Disease Control and Prevention. Rates of positive Covid tests have also been increasing in recent weeks, the CDC says, specifically in the southern region of the country. N.B.1.8.1 is the current dominant variant in the United States, accounting for 43% of all new Covid cases, according to the CDC. It's an offshoot of the XVD.1.5.1 strain, a descendant of the omicron variant. N.B.1.8.1 was responsible for a surge in hospitalizations in China earlier this year. It's been nicknamed 'razor blade throat,' as there have been anecdotal reports of some people getting painful sore throats, said Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center in Nashville, Tennessee. Schaffner noted, however, that sore throats have been a common symptom of Covid since it first began spreading. 'I doubt the clinical spectrum of Covid has changed substantially,' Schaffner said. Do I need a Covid booster? When will the new vaccines be available? The uptick in cases comes as many Americans have likely gone a year or longer without a Covid shot. In May, the Food and Drug Administration asked drugmakers to update their Covid vaccines to target the LP.8.1 strain, a descendent of JN.1, which began spreading widely in 2023 and is another offshoot of omicron. LP.8.1 currently accounts for 31% of all new cases, per the CDC. The new shots won't be available until the fall, and are expected to be approved only for adults 65 and up and kids and adults with at least one medical condition that puts them at risk of severe illness. Healthy kids and adults who want a shot may have to find an older version or pay out of pocket. A single dose can cost as much as $140. Experts say, however, that population immunity — whether from vaccination, prior infection or both — may shield much of the public for now. 'While we don't have a lot of high level of immunity in the population right now, because it's been so long, we may have enough low level immunity to just make it a little bit harder for that virus to transmit easily from person to person,' said Andy Pekosz, an infectious disease researcher at Johns Hopkins University. Indeed, weekly hospitalization rates have remained low, suggesting that the new variant may not be leading to severe illness. The number of cases are still drastically lower than those this time last year, when the test positivity rate peaked in August at 17.9%. The 2025 season has yet to scrape 5%. Pekosz said it isn't unusual for cases to rise during the summer time, when people are likely to crowd indoors to escape the heat. However, he believes that if there is a summer surge of cases, it will be a small one. 'The variants have been around for a while and haven't caused any major surges up until date,' Pekosz said. 'So again, I'm hopeful that if we see a surge, it'll be a low level surge compared to previous years.' Dr. Ofer Levy, director of the precision vaccines program at Boston Children's Hospital, who has advised the FDA, said people who are at high risk of severe illness still may want to consider getting a Covid shot, if they can find one. High risk groups include: Older adults People with weakened immune systems Pregnant women Those with underlying health conditions, such as asthma and heart disease Getting a shot is especially important, Levy said, for those who haven't had one in over a year and whose immunity has likely waned. 'If you're in a high risk group and you're in a state where cases are rising, you may want to just get the first available appointment and get a shot to protect yourself,' he said. People at high risk can then consider getting an additional Covid shot when the updated vaccines are distributed in the fall, he said. Covid has two waves a year Schaffner, of Vanderbilt, said people in the high risk groups may also want to consider wearing a mask during indoor activities, such as the movies. Healthy adults and children may be able to wait longer before getting another shot, Levy added. 'If you're in a lower risk group, that's where things get fuzzy,' he said. 'I mean if you want a vaccine and your health care provider concurs and you can get it.' Dr. Michael Phillips, an infectious disease doctor at NYU Langone, said that he sees mostly immunocompromised and older adults test positive for the virus. For those who haven't gotten a Covid shot in years, Phillips said he doesn't think they should worry just yet. 'If you're younger, otherwise healthy, I think you're OK,' Phillips said. 'If you have underlying pulmonary disease, you know, if you're an older age group, now that's a time when you should be really talking to a doctor and saying, 'Gosh, should I be getting a booster for Covid?'' He said that the amount of positive Covid tests NYU Langone has seen has decreased 40% since February. Fatima Amaeka, a senior analyst at the Center for Outbreak Response Innovation at Johns Hopkins, said she expects the current wave to peak around September. Schaffner said to expect another wave in the late fall and winter. '[Covid] has two increases each year,' he said. 'Everyone is familiar with the winter increase that goes along with flu and RSV.'
